Recent Insider Transactions - Monopar Therapeutics (NASDAQ: MNPR)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

03/31/2024

Sell

$0.68

3,098

$2K

57,624

NASDAQ MNPR Monopar Therapeutics

Tsuchimoto Kim R / director, officer: Chief Financial Officer

03/31/2024

Sell

$0.68

4,082

$3K

50,470

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

03/31/2024

Sell

$0.68

7,172

$5K

166,130

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

12/31/2023

Sell

$0.34

3,098

$1K

51,770

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

01/01/2024

Sell

$0.34

2,327

$792

148,828

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

12/31/2023

Sell

$0.34

8,469

$3K

144,431

NASDAQ MNPR Monopar Therapeutics

Tsuchimoto Kim R / director, officer: Chief Financial Officer

01/01/2024

Sell

$0.34

505

$172

44,596

NASDAQ MNPR Monopar Therapeutics

Tsuchimoto Kim R / director, officer: Chief Financial Officer

12/31/2023

Sell

$0.34

4,073

$1K

43,870

NASDAQ MNPR Monopar Therapeutics

RIOUX PATRICE /

01/01/2024

Buy

$0.34

10,000

$3K

10,000

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

09/30/2023

Sell

$0.62

7,172

$4K

128,426

NASDAQ MNPR Monopar Therapeutics

Tsuchimoto Kim R / director, officer: Chief Financial Officer

09/30/2023

Sell

$0.62

3,444

$2K

37,986

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

09/30/2023

Sell

$0.62

2,624

$2K

45,916

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

06/30/2023

Sell

$0.86

4,057

$3K

39,587

NASDAQ MNPR Monopar Therapeutics

Tsuchimoto Kim R / director, officer: Chief Financial Officer

06/30/2023

Sell

$0.86

5,104

$4K

31,474

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

06/30/2023

Sell

$0.86

10,269

$9K

111,124

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

03/31/2023

Sell

$1.39

4,286

$6K

86,354

NASDAQ MNPR Monopar Therapeutics

Tsuchimoto Kim R / director, officer: Chief Financial Officer

03/31/2023

Sell

$1.39

1,842

$3K

21,732

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

03/31/2023

Sell

$1.39

1,154

$2K

29,803

NASDAQ MNPR Monopar Therapeutics

Anderson Raymond / director

02/01/2023

Buy

$3.16

13,930

$44K

13,930

NASDAQ MNPR Monopar Therapeutics

Brown Michael J / director

02/01/2023

Buy

$3.16

13,930

$44K

13,930

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

02/01/2023

Buy

$3.16

221,839

$701K

221,839

NASDAQ MNPR Monopar Therapeutics

KLAUSNER ARTHUR J / director

02/01/2023

Buy

$3.16

13,930

$44K

13,930

NASDAQ MNPR Monopar Therapeutics

Tsuchimoto Kim R / officer: Chief Financial Officer

02/01/2023

Buy

$3.16

102,688

$324K

102,688

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

02/01/2023

Buy

$3.16

102,688

$324K

102,688

NASDAQ MNPR Monopar Therapeutics

STARR CHRISTOPHER M / director

02/01/2023

Buy

$3.16

13,930

$44K

13,930